Download

Full Text

• Spirito, P., Bellone, P., Harris, K.M., Bernabo, P., Bruzzi, P., Maron, B.J., Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy (2000) New England Journal of Medicine, 342 (24), pp. 1778-1785. , DOI 10.1056/NEJM200006153422403
• Maron, B.J., Casey, S.A., Poliac, L.C., Clinical course of hypertrophic cardiomyopathy in a regional United States cohort (1999) JAMA, 281, pp. 650-655
• Maron, B.J., Casey, S.A., Hauser, R.G., Clinical course of hypertrophic cardiomyopathy with survival to advanced age (2003) J Am Coll Cardiol, 42, pp. 882-888
• Shah, P.M., Gramiak, R., Adelman, A.G., Echo-cardiographic assessment of the effects of surgery and propranolol on the dynamics of outflow obstruction in hypertrophic subaortic stenosis (1972) Circulation, 45, pp. 516-521
• Maron, M.S., Olivotto, I., Betocchi, S., Casey, S.A., Lesser, J.R., Losi, M.A., Cecchi, F., Maron, B.J., Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy (2003) New England Journal of Medicine, 348 (4), pp. 295-303. , DOI 10.1056/NEJMoa021332
• Nagueh, S.F., Ommen, S.R., Lakkis, N.M., Killip, D., Zoghbi, W.A., Schaff, H.V., Danielson, G.K., Spencer III, W.H., Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy (2001) Journal of the American College of Cardiology, 38 (6), pp. 1701-1706. , DOI 10.1016/S0735-1097(01)01614-X, PII S073510970101614X
• Gietzen, F.H., Leuner, Ch.J., Raute-Kreinsen, U., Dellmann, A., Hegselmann, J., Strunk-Mueller, C., Kuhn, H.J., Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy (1999) European Heart Journal, 20 (18), pp. 1342-1354. , DOI 10.1053/euhj.1999.1520
• Xin, J., Shiota, T., Lever, H.M., Kapadia, S.R., Sitges, M., Rubin, D.N., Bauer, F., Thomas, J.D., Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery (2001) Journal of the American College of Cardiology, 38 (7), pp. 1994-2000. , DOI 10.1016/S0735-1097(01)01656-4, PII S0735109701016564
• Hoffer, E., Bolland, J., Traitement de la cardiomyopathie hypertrophique obstructive par ablation septale percutanée (2002) Rev Med Liege, 57, pp. 433-437
• Faber, L., Seggewiss, H., Welge, D., Fassbender, D., Schmidt, H.K., Gleichmann, U., Horstkotte, D., Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience (2004) European Journal of Echocardiography, 5 (5), pp. 347-355. , DOI 10.1016/j.euje.2004.01.001, PII S1525216704000034